薬物スクリーニングの日本市場：製品・サービス別、サンプルタイプ別、エンドユーザー別、地域別、2025年～2033年

日本の薬物スクリーニングの市場規模は2024年に4億630万米ドルに達しました。IMARC Groupは、市場は2033年までに13億5,330万米ドルに達し、2025年から2033年にかけて14.3%の成長率（CAGR）を示すと予測しています。同市場は、麻薬密売人や地元ディーラーの存在感の高まり、薬物乱用事例の急増、仮想通貨の利用拡大など、いくつかの重要な要因によって推進されています。

本レポートで扱う主な質問

• 日本の薬物スクリーニング市場はこれまでどのように推移し、今後どのように推移するのか？
• COVID-19が日本の薬物スクリーニング市場に与えた影響は？
• 日本の薬物スクリーニング市場の製品・サービス別区分は？
• 日本の薬物スクリーニング市場のサンプルタイプ別区分は？
• 日本の薬物スクリーニング市場のエンドユーザー別区分は？
• 日本の薬物スクリーニング市場のバリューチェーンにおける様々なステージとは？
• 日本の薬物スクリーニングの主要な促進要因と課題は何か？
• 日本の薬物スクリーニング市場の構造と主要プレーヤーは？
• 日本の薬物スクリーニング市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
• 市場推定
• 調査手法

第3章 エグゼクティブサマリー

第4章 日本の薬物スクリーニング市場 - イントロダクション

• 概要
• 市場力学
• 業界動向
• 競合情報

第5章 日本の薬物スクリーニング市場情勢

• 過去・現在の市場動向（2019～2024年）
• 市場予測（2025～2033年）

第6章 日本の薬物スクリーニング市場：製品・サービス別の内訳

• 装置
• 迅速検査デバイス
• 消耗品
• ラボサービス

第7章 日本の薬物スクリーニング市場：サンプルタイプ別の内訳

• 尿サンプル
• 呼気サンプル
• 口腔液サンプル
• 毛髪サンプル
• その他

第8章 日本の薬物スクリーニング市場：エンドユーザー別の内訳

• 病院
• 薬物検査研究所
• 職場
• 薬物治療センター
• 疼痛管理センター
• 個人ユーザー
• 刑事司法制度・法執行機関

第9章 日本の薬物スクリーニング市場 - 競合情勢

• 概要
• 市場構造
• 市場企業のポジショニング
• 主要成功戦略
• 競合ダッシュボード
• 企業評価象限

第10章 主要企業のプロファイル

第11章 日本の薬物スクリーニング市場：業界分析

• 促進要因・抑制要因・機会
• ポーターのファイブフォース分析
• バリューチェーン分析

第12章 付録

Japan drug screening market size reached USD 406.3 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,353.3 Million by 2033, exhibiting a growth rate (CAGR) of 14.3% during 2025-2033. The market is being propelled by several significant factors, including the escalating presence of drug traffickers and local dealers, a surge in substance abuse cases, and the growing utilization of virtual currencies.

Drug screening involves the procedure of collecting and examining an individual's blood, urine, hair, or saliva to identify the presence of substances and chemicals indicative of drug use. This process encompasses a wide array of testing methods, including enzyme immunoassays (IAs), gas chromatography (GC), and liquid chromatography/mass spectrometry (LC/MS), which is considered a superior and highly precise confirmation test utilized when initial results show positive. Its primary purpose is to detect both the legitimate and illegitimate use of drugs, spanning illegal substances like cocaine, heroin, and 3,4-Methylenedioxymethamphetamine (MDMA). Additionally, it is employed to identify the misuse of various prescription medications when they are consumed differently or in excessive quantities. Drug screening plays a crucial role in clinical trials for evaluating the effectiveness and safety of novel drugs. Moreover, it is an essential component in legal proceedings, serving the purposes of criminal law enforcement. Furthermore, it aids in assessing the potential for abuse and adherence among patients receiving opioid therapy.

Japan Drug Screening Market Trends:

The Japan drug screening market is currently experiencing significant growth driven by a multitude of influential factors. Foremost among these factors is the rising demand for drug screening due to its accuracy and the rapid delivery of results, making it an appealing choice for various applications. Moreover, the increase in cases of substance abuse is a key driver of market expansion, as societies grapple with the challenges of addiction and its consequences. Another factor contributing to the market's growth is the growing prevalence of drug use as a coping mechanism for stress, anxiety, and life's hardships, further emphasizing the need for effective drug screening. Additionally, government agencies are also playing a pivotal role by initiating regular roadside oral fluid screening to detect drug-impaired drivers and launching substance abuse and addiction programs to address the needs of addicts. Furthermore, the presence of drug traffickers and local dealers, facilitated by the use of virtual currencies that offer anonymity to buyers and sellers, is supporting the market's expansion. These factors will collectively contribute to the positive outlook for the drug screening market in Japan over the forecasted period.

Japan Drug Screening Market Segmentation:

Product and Service Insights:

• Equipment
  • Immunoassay Analyzers
  • Chromatography Instruments
  • Breath Analyzers
• Rapid Testing Devices
  • Urine Testing Devices
  • Oral Fluid Testing Devices
• Consumables
  • Assay Kits
  • Sample Collection Cups
  • Calibrators and Controls
  • Others
• Laboratory Services

Sample Type Insights:

• Urine Samples
• Breath Samples
• Oral Fluid Samples
• Hair Samples
• Others

End User Insights:

• Hospitals
• Drug Testing Laboratories
• Workplaces
• Drug Treatment Centers
• Pain Management Centers
• Personal Users
• Criminal Justice System and Law Enforcement Agencies

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan drug screening market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan drug screening market?
• What is the breakup of the Japan drug screening market on the basis of product and service?
• What is the breakup of the Japan drug screening market on the basis of sample type?
• What is the breakup of the Japan drug screening market on the basis of end user?
• What are the various stages in the value chain of the Japan drug screening market?
• What are the key driving factors and challenges in the Japan drug screening?
• What is the structure of the Japan drug screening market and who are the key players?
• What is the degree of competition in the Japan drug screening market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Drug Screening Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Drug Screening Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Drug Screening Market - Breakup by Product and Service

• 6.1 Equipment
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Segmentation
    • 6.1.3.1 Immunoassay Analyzers
    • 6.1.3.2 Chromatography Instruments
    • 6.1.3.3 Breath Analyzers
  • 6.1.4 Market Forecast (2025-2033)
• 6.2 Rapid Testing Devices
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Segmentation
    • 6.2.3.1 Urine Testing Devices
    • 6.2.3.2 Oral Fluid Testing Devices
  • 6.2.4 Market Forecast (2025-2033)
• 6.3 Consumables
  • 6.3.1 Overview
  • 6.3.2 Historical and Current Market Trends (2019-2024)
  • 6.3.3 Market Segmentation
    • 6.3.3.1 Assay Kits
    • 6.3.3.2 Sample Collection Cups
    • 6.3.3.3 Calibrators and Controls
    • 6.3.3.4 Others
  • 6.3.4 Market Forecast (2025-2033)
• 6.4 Laboratory Services
  • 6.4.1 Overview
  • 6.4.2 Historical and Current Market Trends (2019-2024)
  • 6.4.3 Market Forecast (2025-2033)

7 Japan Drug Screening Market - Breakup by Sample Type

• 7.1 Urine Samples
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Forecast (2025-2033)
• 7.2 Breath Samples
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)
• 7.3 Oral Fluid Samples
  • 7.3.1 Overview
  • 7.3.2 Historical and Current Market Trends (2019-2024)
  • 7.3.3 Market Forecast (2025-2033)
• 7.4 Hair Samples
  • 7.4.1 Overview
  • 7.4.2 Historical and Current Market Trends (2019-2024)
  • 7.4.3 Market Forecast (2025-2033)
• 7.5 Others
  • 7.5.1 Historical and Current Market Trends (2019-2024)
  • 7.5.2 Market Forecast (2025-2033)

8 Japan Drug Screening Market - Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2019-2024)
  • 8.1.3 Market Forecast (2025-2033)
• 8.2 Drug Testing Laboratories
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2019-2024)
  • 8.2.3 Market Forecast (2025-2033)
• 8.3 Workplaces
  • 8.3.1 Overview
  • 8.3.2 Historical and Current Market Trends (2019-2024)
  • 8.3.3 Market Forecast (2025-2033)
• 8.4 Drug Treatment Centers
  • 8.4.1 Overview
  • 8.4.2 Historical and Current Market Trends (2019-2024)
  • 8.4.3 Market Forecast (2025-2033)
• 8.5 Pain Management Centers
  • 8.5.1 Overview
  • 8.5.2 Historical and Current Market Trends (2019-2024)
  • 8.5.3 Market Forecast (2025-2033)
• 8.6 Personal Users
  • 8.6.1 Overview
  • 8.6.2 Historical and Current Market Trends (2019-2024)
  • 8.6.3 Market Forecast (2025-2033)
• 8.7 Criminal Justice System and Law Enforcement Agencies
  • 8.7.1 Overview
  • 8.7.2 Historical and Current Market Trends (2019-2024)
  • 8.7.3 Market Forecast (2025-2033)

9 Japan Drug Screening Market - Competitive Landscape

• 9.1 Overview
• 9.2 Market Structure
• 9.3 Market Player Positioning
• 9.4 Top Winning Strategies
• 9.5 Competitive Dashboard
• 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

• 10.1 Company A
  • 10.1.1 Business Overview
  • 10.1.2 Product Portfolio
  • 10.1.3 Business Strategies
  • 10.1.4 SWOT Analysis
  • 10.1.5 Major News and Events
• 10.2 Company B
  • 10.2.1 Business Overview
  • 10.2.2 Product Portfolio
  • 10.2.3 Business Strategies
  • 10.2.4 SWOT Analysis
  • 10.2.5 Major News and Events
• 10.3 Company C
  • 10.3.1 Business Overview
  • 10.3.2 Product Portfolio
  • 10.3.3 Business Strategies
  • 10.3.4 SWOT Analysis
  • 10.3.5 Major News and Events
• 10.4 Company D
  • 10.4.1 Business Overview
  • 10.4.2 Product Portfolio
  • 10.4.3 Business Strategies
  • 10.4.4 SWOT Analysis
  • 10.4.5 Major News and Events
• 10.5 Company E
  • 10.5.1 Business Overview
  • 10.5.2 Product Portfolio
  • 10.5.3 Business Strategies
  • 10.5.4 SWOT Analysis
  • 10.5.5 Major News and Events

11 Japan Drug Screening Market - Industry Analysis

• 11.1 Drivers, Restraints, and Opportunities
  • 11.1.1 Overview
  • 11.1.2 Drivers
  • 11.1.3 Restraints
  • 11.1.4 Opportunities
• 11.2 Porters Five Forces Analysis
  • 11.2.1 Overview
  • 11.2.2 Bargaining Power of Buyers
  • 11.2.3 Bargaining Power of Suppliers
  • 11.2.4 Degree of Competition
  • 11.2.5 Threat of New Entrants
  • 11.2.6 Threat of Substitutes
• 11.3 Value Chain Analysis

12 Appendix